Recent years have seen a considerable media interest in the adverse effects of the selective serotonin reuptake inhibitors (SSRIs). This has led to claims that these antidepressants may lead to suicide and homicide and that they cause dependence or even addiction. Such claims have caused great concerns to many patients and have confused doctors in both primary care and psychiatric practice. In this article I review the basis of these claims and show that many seem to emerge from the misinterpretation of evidence and the use of imprecise definitions. Although the SSRIs are not free of problems they compare very favourably with other antidepressants and other classes of psychotropic drugs. There is no evidence they are addictive in the formal sense of leading to a drug dependence syndrome. Some suggestions on the way these issues can be more precisely defined and studied in future are given.
Andersen H , Kristiansen E S (1959) Tofranil treatment of endogenous depressions . Acta Psych Neurolog Scand34: 387–397
2.
Anderson I , Nutt D J , Deakin J W F (2000) Evidence-based guidelines for treating depressive disorders with anti-depressants: revision of the 1993 British Association for Psychopharmacology guidelines . J Psychopharmacology14: 3–20
3.
Ballenger J C , Davidson J R , Lecrubier Y , Nutt D J , Baldwin D S , den Boer J A , Kasper S , Shear M K (1998a) Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety . J Clin Psychiatry59 (Suppl 8): 47–54
4.
Ballenger J C , Davidson J R , Lecrubier Y , Nutt D J , Bobes J , Beidel D C , Ono Y , Westenberg H G (1998b) Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety . J Clin Psychiatry59 (Suppl 17): 54–60
5.
Ballenger J C , Davidson J R , Lecrubier Y , Nutt D J , Foa E B , Kessler R C , McFarlane A C , Shalev A Y (2000) Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety . J Clin Psychiatry61 (Suppl 5): 60–66
6.
Bazire S (2000) Psychotropic drug directory: the professional’s pocket handbook and aide memoir. Quay Books Division, Mark Allen Publishing, Location
7.
Bell C , Abrams J , Nutt D (2001) Tryptophan depletion and its implications for psychiatry . Br J Psychiatry178: 399–405
8.
Benazzi F (1998) SSRI discontinuation syndrome treated with fluoxetine . Int J Geriatr Psychiatry13: 421–422
9.
Berman R M , Sanacora G , Anand A , Roach L M , Fasula M K , Finkelstein C O , Wachen R M , Oren D A , Heninger G R , Charney D S (2002) Monoamine depletion in unmedicated depressed subjects . Biol Psychiatry51: 469–473
10.
Birmaher B (1998) Should we use antidepressant medications in chidren and adolescents with deprssive disorders?Psychopharmacol Bull34: 35–39
11.
Blier P , de Montigny C (1994) Current advances and trends in the treatment of depression . Trends Pharmacol Sci15: 220–226
12.
Bogetto F , Bellini S , Bonatto Revello R , Patria L (2002) Discontinuation syndrome in dythymic patients treated with selective serotonin reuptake inhibitors . CNS Drugs16: 273–283
13.
Bosker F J , Klompmakers A A , Westenberg H G (1995) Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat . Neuropharmacology34: 501–508
14.
Busto U , Sellers E M , Naranjo C A , Cappell H , Sanchez-Craig M , Sykora K (1986) Withdrawal reaction after long-term therapeutic use of benzodiazepines . N Engl J Med315: 854–859
15.
Coupland N J , Bell C J , Potokar J P (1996) Serotonin reuptake inhibitor withdrawal . J Clin Psychopharmacol16: 356–362
16.
Cowen P J , Nutt D J (1982) Abstinence symptoms after withdrawal of tranquillizing drugs: is there a common neurochemical mechanism?Lancet2: 360–362
17.
de Montigny C , Chaput Y , Blier P (1990) Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers . J Clin Psychiatry51 (Suppl B): 4–8
18.
De Moore G M , Robertson A R (1996) Suicide in the 18 years after deliberate self-harm a prospective study . Br J Psychiatry169: 489–494
19.
de Wit H , Griffiths R R (1991) Testing the abuse liability of anxiolytic and hypnotic drugs in humans . Drug Alcohol Depend28: 83–111
Donovan S , Clayton A , Beeharry M , Jones S , Kirk C , Waters K , Gardner D , Faulding J , Madeley R (2000) Deliberate self-harm and antidepressant drugs. Investigation of a possible link . Br J Psychiatry177: 551–556
22.
Edwards G , Arif A , Hadgson R (1981) Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum . Bull World Health Organ59: 225–242
23.
Ellenbogen M A , Young S N , Dean P , Palmour R M , Benkelfat C (1999) Acute tryptophan depletion in healthy young women with a family history of major affective disorder . Psychol Med29: 35–46
24.
Farrow A , Hull M G , Northstone K , Taylor H , Ford W C , Golding J (2002) Prolonged use of oral contraception before a planned pregnancy is associated with a decreased risk of delayed conception . Hum Reprod17: 2754–2761
25.
Frank E , Prien R F , Jarrett R B , Keller M B , Kupfer D J , Lavori P W , Rush A J , Weissman M M (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence . Arch Gen Psychiatry48: 851–855
26.
Gaind R N , Jacoby R (1978) Benzodiazepines causing aggression. In Gaind R N , Hudson B L , eds, Current themes in psychiatry, pp. 371–379. Macmillan, London
27.
Garner E M , Kelly M W , Thompson D F (1993) Tricyclic anti-depressant withdrawal syndrome . Ann Pharmacother27: 1068–1072
28.
Geddes J R , Carney S M , Davies C , Furakawa T A , Kupfer D J , Frank E , Goodwin G M (2003) replapse prevention with antidepressant drug treatment in depressive disorders : a systematic review Lancet361: 653–661
29.
Gomez T H , Roache J D , Meisch R A (2002) Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys . Psychopharmacology (Berl)161: 86–94
30.
Goodwin G M (1994) Recurrence of mania after lithium withdrawal . Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry164: 149–152
31.
Haddad P (1998) The SSRI discontinuation syndrome . J Psychopharmacol12: 305–313
32.
Haddad P (1999) Do antidepressants have any potential to cause addiction?J Psychopharmacol13: 300–307
33.
Harris E C , Barraclough B (1997) Suicide as an outcome for mental disorders; a meta-analysis . Br J Psychiatry170: 205–228
34.
Harrison-Read P E , Tyrer P , Lawson C , Lack S , Fernandes C , File SE (1996) Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence . J Psychopharmacol10(2): 89–97
35.
Healy D (2000) Emergence of antidepressant induced suicidality . Primary Care Psychiatry6: 23–28
36.
Healy D (2002) SSRIs and deliberate self-harm . Br J Psychiatry180: 547-547
37.
Healy D (2003) Lines of evidence on the risks of suicide with the SSRIs . Psychother Psychosomat22: 72–79
38.
Healy D , Tranter R (1999) Pharmacological stress diathesis syndromes . J Psychopharmacol13: 287–290
39.
Healy D , Langmaak C , Savage M (1999) Suicide in the course of the treatment of depression . J Psychopharmacol13: 94–99
40.
Henry J A (1997) Epidemiology and relative toxicity of anti-depressant drugs in overdose . Drug Safety16: 374–390
41.
Holton A , Riley P , Tyrer P (1992) Factors predicting long-term outcome after chronic benzodiazepine therapy . J Affect Disord24: 245–252
42.
House A , Owens D , Patchett L (2001) Deliberate self harm. Effective health care bulletin centre for reviews and dissemination. University of York, York
43.
Isacsson G , Holmgren P , Druid H , Bergman U (1997) The utilization of antidepressants–a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992–1994 . Acta Psychiatr Scand96: 94–100
44.
Jick S S , Dean A D , Jick H (1995) Antidepressants and suicide . BMJ310: 215–218
45.
Kahn R S , Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonin function . Biol Psychiatry30: 1139–1166
46.
Kales A , Manfredi R L , Vgontzas A N , Bixler E O , Vela-Bueno A , Fee E C (1991) Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines . Clin Pharmacol Ther49: 468–476
47.
Khan A , Khan S , Kolts R Brown W A (2003) Suicide rates in clinical trials of SSRIs, other antidepressants and placebo: analysis of FDA reports . Am J Psychiatry160: 790–792
48.
Khan A , Warner H A , Brown W A (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database . Arch Gen Psychiatry57: 311–317
49.
Kramer J D , Klein D F , Fink M (1961) withdrawal symptoms following discontinuation of imipramine therapy . Am J Psychiatry118: 549–550
50.
Kupfer D J (1991) J Long term treatment of depression Clin Psychiatry52 (Suppl 5): 28–34
51.
Kupfer D J , Frank E , Perel J M , Cornes C , Mallinger A G , Thase M E , McEachran A B , Grochocinski V J (1992) Five-year outcome for maintenance therapies in recurrent depression . Arch Gen Psychiatry49: 769–773
52.
Lewis G , Hawton K , Jones P (1997) Strategies for preventing suicide . Br J Psychiatry171: 351–354
53.
Lingford-Hughes A , Nutt D J (2003) The neurobiology of addiction and implications for treatment . Br J Psychiatry182: 97–100 .
54.
Malizia A L , Nutt D J (1995) The effects of flumazenil in neuropsychiatric disorders . Clin Neuropharmacol18: 215–232 .
55.
Malizia A L , Cunningham V J , Bell C J , Liddle P F , Jones T , Nutt D J (1998) Decreased brain GABAA-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study . Arch Gen Psychiatry55: 715–720
Medawar C (1997) The Antidepressant Web–marketing depression and making medicines work . Int J Risk Safety Med10(2): 75–126
58.
Michelson D , Fava M , Amsterdam J , Apter J , Londborg P , Tamura R , Tepner R G (2000) Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial . Br J Psychiatry176: 363–368
59.
Montgomery S , Cronholm B , Asberg M , Montgomery D B (1978) Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline . Br J Clin Pharmacol00 (Suppl 1): 77S–80S
60.
Montgomery S A , Dunbar G (1993) Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression . Int Clin Psychopharmacol8: 189–195
61.
Montgomery S A , Roberts A , Patel A G (1994) Placebo-controlled efficacy of antidepressants in continuation treatment . Int Clin Psychopharmacol9 (Suppl 1): 49–53
62.
Neumeister A , Konstantinidis A , Stastny J , Schwarz MJ , Vitouch O , Willeit M , Praschak-Rieder N , Zach J , de Zwaan M , Bondy B , Ackenheil M , Kasper S (2002) Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression . Arch Gen Psychiatry59: 613–620
63.
Nutt D J (1986) Benzodiazepine dependence in the clinic: reason for anxiety?Trends Pharmacol Sci7: 457–460
64.
Nutt D J , Malizia A L (2001) New insights into the role of the GABA A benzodiazepine receptor . Br J Psychiatry179: 390–396
65.
Price J S , Waller P C , Wood S M , MacKay A V (1996) A comparison of the post marketing safety of four SSRIs including the investigation of symptoms on withdrawal . Br J Clin Pharmacol42: 757–763
66.
Ramos-Brieva J A , Cordero-Villafáfila A (1989) Aggressiveness or low control of impulsiveness?: two hypotheses about suicide in depressives . Med Sci Res17: 229–230
67.
Rickels K , Case G W , Winokur A , Swenson C (1984) Long-term benzodiazepine therapy: benefits and risks . Psychopharmacol Bull20: 608–615
68.
Rosenbaum J F , Fava M , Hoog S L , Ascroft R C , Krbs W B (1998) SSRI discontinuation syndrome: a randomised clinical trial . Biol Psychiatry44: 757–763
69.
Rupp H , Maisch B , Brilla CG (1996) Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine . Cardiovasc Drugs Ther10 (Suppl 1): 251–262
70.
Schatzberg A F , Haddad P , Kaplan E M , Lejoyeux M , Rosenbaum J F , Young A H , Zajecka J (1997) SSRI discontinuation syndrome: a hypothetical definition . J Clin Psychiatry58: 5–10
71.
Schindler C W , Panlilio L V , Goldberg S R (2002) Second-order schedules of drug self-administration in animals . Psychopharmacology (Berl)163: 327–344
72.
Schweizer E , Rickels K , Case W G , Greenblatt D J (1990) Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper . Arch Gen Psychiatry47: 908–915
73.
Smith T D , Kuczenski R , George-Friedman K , Malley J D , Foote S L (2000) In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration . Synapse38: 460–470
74.
Solomon D A , Keller M B , Leon A C , Mueller T I , Lavori P W , Shea M T , Coryell W , Warshaw M , Turvey C , Maser J D , Endicott J (2000) Multiple recurrences of major depressive disorder . Am J Psychiatry157: 229–233
75.
Storosum J G , van Zwieten B J , van den Brink W , Gersons B P , Broekmans A W (2001) Suicide risk in placebo-controlled studies of major depression . Am J Psychiatry158: 1271–1275
76.
Tanriverdi N , Yazici K M (1996) Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report . Biol Psychiatry39: 814–815
77.
Tiihonen J , Kuikka J , Rasanen P , Lepola U , Koponen H , Livska A , Lehmusvaara A , Vainio P , Kononen M , Bergstrom K , Yo M , Kinnunen I , Akerman K , Karhu J (1997) Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractional analysis . Mol Psychiatry2: 463–471
78.
Tranter R , Healy D (1998) Neuroleptic discontinuation syndromes . J Psychopharmacol12: 401–406
79.
Tyrer P , Owen R , Dawling S (1983) Gradual withdrawal of diazepam after long-term therapy . Lancet1: 1402–1406
80.
Vogel G W , Buffenstein A , Minter K , Hennessey A (1990) Drug effects on REM sleep and on endogenous depression . Neurosci Biobehav Rev14: 49–63
81.
Warner H A , Brown W A (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database . Arch Gen Psychiatry57: 311–317
82.
Wilson S J , Bailey J E , Alford C , Weinstein A , Nutt D J (2002) Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood . J Psychopharmacol16: 321–331
83.
World Health Organisation (2003) Expert committee report on drug dependence. WHO, Geneva
84.
Worthington J , Fava M , Davidson K , Alpert J , Nierenberg A A , Rosenbaum J F (1995) Patterns of improvement in depressive symptoms with fluoxetine treatment . Psychopharmacol Bull31: 223–226
85.
Zajeka J , Fawcett J , Amsterdam J.Quitkin F , Reimherr F , Rosenbaum J , Michelson D , Beasley C (1998) Safety of abrupt discontinuation of fluoxetine: a randomised placebo-controlled study . J Clin Psychiatry18: 193–197
86.
Zawertailo L A , Busto U , Kaplan H L , Sellers E M (1995) Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans . J Clin Psychopharmacol15: 117–124
